Last $14.29 USD
Change Today +0.14 / 0.99%
Volume 147.1K
OSIR On Other Exchanges
As of 8:10 PM 08/29/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Michelle LeRoux Williams Ph.D.

Former Chief Scientific Officer, Osiris Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 1 different industries.

As of Fiscal Year 2013


Dr. Michelle LeRoux Williams, Ph.D served as the Chief Scientific Officer of Osiris Therapeutics, Inc. from May 2007 to April 15, 2014. Dr. Williams served as Vice President of Development of Osiris Therapeutics, Inc. since May 2007. Dr. Williams joined Osiris in 2001 as the Director of Orthopedics and was responsible for the development of Osteocel from the initial concept through product launch in 2005. Dr. Williams also advanced the Chondrogen program from preclinical ...

Read Full Background

Corporate Headquarters*

7015 Albert Einstein Drive
Columbia, Maryland 21046

United States

Phone: 443-545-1800
Fax: 443-545-1701

Board Members Memberships*

There is no Board Members Memberships data available.


Bachelor's Degree
Rice University
Duke University
Unknown/Other Education
Columbia University

Other Affiliations*

Annual Compensation*

Total Annual Compensation$318,833

Stock Options*

Exercised Options24,500
Exercised Options Value$301,656
Exercisable Options102,500
Unexercisable Options66,250
Total Value of Options$301,656
Total Number of Options193,250

Total Compensation*

Total Annual Cash Compensation$318,833
Total Short Term Compensation$318,833
Total Calculated Compensation$418,833
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
OSIR:US $14.29 USD +0.14


Michael D. West Ph.D.Chief Executive Officer, President and Director
BioTime, Inc.
Thomas Axelsson M.Sc.Chief Executive Officer
Vitrolife AB (publ)
Keith Murphy Chairman, Chief Executive Officer, President, Member of Audit Committee and Member of Science & Technology Committee
Organovo Holdings, Inc.
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact OSIRIS THERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at